
Zydus Lifesciences Limited has informed the Exchange about press release dated 16-Sep-2022 titled Zydus receives tentative approval from the USFDA for Sugammadex Injection
Filed with NSE ·

Zydus Lifesciences Limited has informed the Exchange about press release dated 16-Sep-2022 titled Zydus receives tentative approval from the USFDA for Sugammadex Injection
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences